Cardiovascular risk assessment, cardiovascular disease risk factors, and lung function parameters
Maciej Polak(Jagiellonian University), Andrzej Pająk(Jagiellonian University), Krystyna Szafraniec(Jagiellonian University), Agnieszka Doryńska(Institute of Cardiology)
Cited by 10
Related Papers
SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe
|European Heart Journal|2021|1.7k
HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials
|The Lancet|2014|713
PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study
|The Lancet Diabetes & Endocrinology|2016|391
Education and wealth inequalities in healthy ageing in eight harmonised cohorts in the ATHLOS consortium: a population-based study
|The Lancet Public Health|2020|160